Cargando…
Major adverse cardiac events and drug-coated balloon size in coronary interventions
OBJECTIVE: In-stent restenosis (ISR) is a feared complication after coronary stent implantation. Drug-coated balloon (DCB) is being promoted as a treatment option for ISR. However, the benefit-risk ratio of DCB length has not been investigated. Longer DCBs release more anti-proliferative drug to the...
Autores principales: | Naguib, David, Knoop, Betül, Dannenberg, Lisa, Liebsch, Eva, Pöhl, Martin, Helten, Carolin, Assadi-Schmidt, Athena, Kelm, Malte, Zeus, Tobias, Polzin, Amin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998862/ https://www.ncbi.nlm.nih.gov/pubmed/29848922 http://dx.doi.org/10.14744/AnatolJCardiol.2018.67864 |
Ejemplares similares
-
S1P Lyase Inhibition Starting After Ischemia/Reperfusion Improves Postischemic Cardiac Remodeling
por: Polzin, Amin, et al.
Publicado: (2022) -
TAVR: nemesis of NOACs?
por: Polzin, Amin, et al.
Publicado: (2022) -
Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis
por: Polzin, Amin, et al.
Publicado: (2022) -
European NSTEMI guidelines—return of clopidogrel?
por: Dannenberg, Lisa, et al.
Publicado: (2021) -
Risk prediction of bleeding and MACCE by PRECISE-DAPT score post-PCI
por: Dannenberg, Lisa, et al.
Publicado: (2021)